• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 1.54% Nasdaq Down 1.52%

    Ariad Pharmaceuticals Inc. (ARIA)

    -NasdaqGS
    8.99 Down 0.11(1.21%) Apr 17, 4:00PM EDT
    |After Hours : 8.97 Down 0.02 (0.22%) Apr 17, 4:47PM EDT
    Add to Portfolio
    Prev Close:9.10
    Open:9.10
    Bid:8.91 x 3500
    Ask:9.05 x 2500
    1y Target Est:8.14
    Beta:1.17
    Earnings Date:May 5 - May 11 (Est.)
    Day's Range:8.86 - 9.23
    52wk Range:4.90 - 9.23
    Volume:5,521,995
    Avg Vol (3m):6,015,370
    Market Cap:1.69B
    P/E (ttm):N/A
    EPS (ttm):-0.87
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for ARIA

    Comparison

    Symbol% ChgMkt Cap
    ARIADown 1.21%1.69B
    NVSDown 0.82%245.76B
    PFEDown 0.43%214.76B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):16.19
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-1.05
    Quarterly EPS Est (Mar-15) :-0.26
    Mean Recommendation*:2.4
    PEG Ratio (5 yr expected):-0.21

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    ARIAD Pharmaceuticals, Inc., an oncology company, engages in the discovery, development, and commercialization of medicines for cancer patients. The company offers Iclusig (ponatinib), a tyrosine kinase inhibitor (TKI) for the treatment of adult p... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback